BPY2DP

Across TCGA pan-cancer cohorts, BPY2DP RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated BPY2DP data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher BPY2DP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BPY2DP expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

UCEC, HNSC, and KIRP are the cancer types where BPY2DP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.198	0.873	<.001	108	view →
HNSC	DFS	Tertile	IV	0.887	0.517	.003	108	view →
KIRP	OS	Tertile	All	0.645	0.951	<.001	24	view →
STAD	OS	Tertile	All	0.100	0.539	.014	18	view →
KIRC	OS	Tertile	II,III,IV	0.279	0.576	.017	15	view →
LUAD	OS	Tertile	All	0.243	0.684	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

BPY2DP–UCEC (OS)

Open the UCEC breakdown →